Spots Global Cancer Trial Database for cryptococcosis
Every month we try and update this database with for cryptococcosis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Cryptococcus Neoformans Infection in Patients Not Infected With HIV and Complications Associated With Cryptococcus Neoformans Infection | NCT00001701 | Cryptococcosis | - | National Institutes of Health Clinical Center (CC) | ||
Derivation and Validation of a Scoring System to Distinguish Cryptococcosis and Adenocarcinoma in Pulmonary Nodules | NCT04554875 | Cryptococcosis Lung Adenocarci... | A scoring syste... | - | Shanghai Pulmonary Hospital, Shanghai, China | |
Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Cryptococcus Neoformans Infection in Patients Not Infected With HIV and Complications Associated With Cryptococcus Neoformans Infection | NCT00001701 | Cryptococcosis | - | National Institutes of Health Clinical Center (CC) | ||
Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Cryptococcus Neoformans Infection in Patients Not Infected With HIV and Complications Associated With Cryptococcus Neoformans Infection | NCT00001701 | Cryptococcosis | - | National Institutes of Health Clinical Center (CC) | ||
Derivation and Validation of a Scoring System to Distinguish Cryptococcosis and Adenocarcinoma in Pulmonary Nodules | NCT04554875 | Cryptococcosis Lung Adenocarci... | A scoring syste... | - | Shanghai Pulmonary Hospital, Shanghai, China |